Evidence map›Paper›PMID 42645145›Full record

ArticleClinics and practice2026

Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

Friba Nurmukhammad, Sholpan Zhangelova, Akhmetzhan Sugraliyev, Alexander Arutyunov, Yermagambet Kuatbayev, Zhanetta Mukanova, Dina Kapsultanova

Abstract read
In one paragraph

Article in Clinics and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Friba NurmukhammadFaculty of Postgraduate Medical Education, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 161200, Kazakhstan.ORCID 0000-0002-6312-4479
Sholpan ZhangelovaDepartment of Internal Diseases, School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0003-3702-5642
Akhmetzhan SugraliyevDepartment of Internal Diseases, School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0002-8255-4159
Alexander ArutyunovDepartment of Internal Diseases, School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0003-1180-3549
Yermagambet KuatbayevCity Cardiology Center, Almaty 050012, Kazakhstan.
Zhanetta MukanovaDepartment of Internal Diseases, School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0001-5272-1190
Dina KapsultanovaDepartment of Internal Diseases, School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0003-1449-4438

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical risk stratificationclopidogrelcoronary artery diseasedual antiplatelet therapyexploratory risk scorein-hospital mortalitypercutaneous coronary intervention

Identifiers

PMID42645145
PMCPMC13511506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.